Sunday, October 18, 2015

Key Players in the Anti-snoring Treatments Market Pursue New Product Launches and Acquisitions as their Key Growth Strategies

The anti-snoring treatments market is highly fragmented with several global as well as local players. The oral appliances segment dominates the anti-snoring devices market. Some of the key players in the oral appliances market include Sleeping Well, LLC (U.S.), Apnea Sciences Corporation (U.S.), Tomed Dr. Toussaint GmbH (Germany), Sleep Well Enjoy Life, Ltd. (U.K.), and MEDiTAS Ltd. (U.K.). 

Anti-snoring product manufacturers are focusing on product awareness to gain higher market shares. In order to achieve this, manufacturers are focusing on advertising their products through different channels. Each year, over millions of dollars is spent on the Internet, TV, radio, and print advertisements. According to industry experts, in the past few years, the spending on product advertisement has increased by 25% to 50%. In addition to this, players are focusing on launching new and advanced products. For instance, in October 2013, Airway Management Inc. (U.S.) launched myTAP boil and bite mandibular advancement device (MAD), and in June 2012, Theravent, Inc. (U.S.) launched Theravent Advanced Nightly Snore Therapy.

The key strategies followed by most companies in this market are new product launches, acquisitions, agreements, and expansions. New product launches accounted for the largest share of the overall growth strategies mapped from 2012 to 2015. Apnea Sciences Corporation (U.S.), Sleep Well Enjoy Life Ltd. (U.K.), Airway Management, Inc. (U.S.), Theravent, Inc. (U.S.), and Meditas, Ltd. (U.K.) adopted this strategy.

Post a Comment